Correlation Between Jinhe Biotechnology and Shanghai Bailian

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and Shanghai Bailian at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and Shanghai Bailian into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jinhe Biotechnology Co and Shanghai Bailian Group, you can compare the effects of market volatilities on Jinhe Biotechnology and Shanghai Bailian and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of Shanghai Bailian. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and Shanghai Bailian.

Diversification Opportunities for Jinhe Biotechnology and Shanghai Bailian

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Jinhe and Shanghai is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and Shanghai Bailian Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Bailian and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with Shanghai Bailian. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Bailian has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and Shanghai Bailian go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and Shanghai Bailian

Assuming the 90 days trading horizon Jinhe Biotechnology Co is expected to generate 1.15 times more return on investment than Shanghai Bailian. However, Jinhe Biotechnology is 1.15 times more volatile than Shanghai Bailian Group. It trades about 0.0 of its potential returns per unit of risk. Shanghai Bailian Group is currently generating about -0.01 per unit of risk. If you would invest  511.00  in Jinhe Biotechnology Co on November 28, 2024 and sell it today you would lose (71.00) from holding Jinhe Biotechnology Co or give up 13.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.79%
ValuesDaily Returns

Jinhe Biotechnology Co  vs.  Shanghai Bailian Group

 Performance 
       Timeline  
Jinhe Biotechnology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Jinhe Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Jinhe Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Shanghai Bailian 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Shanghai Bailian Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Jinhe Biotechnology and Shanghai Bailian Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jinhe Biotechnology and Shanghai Bailian

The main advantage of trading using opposite Jinhe Biotechnology and Shanghai Bailian positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, Shanghai Bailian can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Bailian will offset losses from the drop in Shanghai Bailian's long position.
The idea behind Jinhe Biotechnology Co and Shanghai Bailian Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated